Stroke Clinical Trial
Official title:
The Effect of Using Functional Electric Stimulation for the Recovery of Dorsiflexion During Rehabilitation of Gait Function, in the Subacute Phase After Stroke- a Randomized Controlled Exploratory Study
The purpose of this project is to investigate the effect of functional electrical stimulation (FES) for recovery of dorsiflexion after stroke. It will be led from the University Department of Rehabilitation Medicine at Danderyd Hospital (RMDS) in collaboration with the MoveAbility Lab at KTH Royal Institute of Technology. Patients referred to RMDS for inpatient rehabilitation early after hemiparetic stroke will be included. The overall aim is to explore how 4 weeks of training incorporating the FES-system (L300 Go System ® Bioness, Ottobock) effect function of the lower extremity, gait function and mobility when compared to conventional training only, in the subacute stage after stroke.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | February 2024 |
Est. primary completion date | December 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Eligible will be patients who have suffered a stroke, verified by CT or MRI examination and are admitted to inpatient care at the University Department of Rehabilitation Medicine Stockholm, Danderyd Hospital in Sweden where approximately 220 patients are treated annually (Stroke (50%)). Inclusion criteria: - 20 participants with hemiplegia - Dependence in ambulation (0- 4 according to the Functional Ambulation Categories) - >= 50 points on the Trunc Control Test. - Impaired dorsiflexion manifested as impaired voluntarily dorsiflex and to hold the ankle in a dorsiflexed position while sitting and for ambulatory participants: during swing phase and heel strike while walking as demonstrated by visual inspection during gait analysis performed by the physiotherapist. - Recommended to be fitted with an ankle-foot orthosis (AFO) by an experienced physiotherapist. - Able to understand study information and to give informed consent. Exclusion Criteria: - Contracture severely restricting gait movements at any lower limb joint - Cardiovascular or other somatic condition incompatible with intensive gait training - Notifiable infectious disease, contagious infections (e.g. Methicillin Resistant Staphylococcus Aureus (MRSA) or Extended Spectrum Beta Lactamase bacteria (ESBL)). - Not able to participate in the rehabilitation intervention due to behavioral disorder or psychiatric disease. - The FES-system L300 Go ® should not be used if a the patient has a pacemaker, defibrillator or any electrical implant, a metallic implant in the affected leg, a cancerous lesion in the affected leg, a fracture or dislocation in the affected leg or if the affected leg is swollen, infected, or has inflamed areas or skin eruptions, such as phlebitis, thrombophlebitis, and varicose veins in the affected leg or if the patient is pregnant. |
Country | Name | City | State |
---|---|---|---|
Sweden | Department of Rehabilitation Medicine, Danderyd Hospital | Danderyd | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Danderyd Hospital | KTH Royal Institute of Technology |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Gait Profile Score (GPS) | GPS is a single index measure that summarises the overall deviation of kinematic gait data relative to normative data. The GPS can be decomposed to provide the Gait Variable Score (GVS) (an index that measures single gait variable deviation), for nine key relevant kinematic variables. A larger GPS indicates greater deviation from normal gait | At baseline and after completion of the 4 week intervention to assess change. | |
Primary | Ankle Sagittal range (degrees) | Assesses range of motion in the ankle (plantarflexion from 0-50 degrees, dorsiflexion from 0-20 degrees) | At baseline and after completion of the 4 week intervention to assess change. | |
Primary | Ankle Positive work | Assesses the force at the ankle joint (J/kg) detected in gait laboratory | At baseline and after completion of the 4 week intervention to assess change. | |
Primary | Step length | Step length will be assessed in the gait laboratory with 3D gait analyses | At baseline and after completion of the 4 week intervention to assess change. | |
Primary | 6 minutes walk test | Assesses walking endurance in meters walked | At baseline and after completion of the 4 week intervention to assess change. | |
Primary | Rated Perceived Exertion (RPE) Scale | Ratings (min 6, max 20) according to the RPE scale are made at the end of the 6 minutes walk test. A higher score indicates a higher degree of perceived exertion. | At baseline and after completion of the 4 week intervention to assess change. | |
Secondary | The Montreal Cognitive Assessment (MoCa) | Assesses mental function (0p max impairment summed up to 30p no detected impairment) | At baseline and after completion of the 4 week intervention to assess change. | |
Secondary | Fugl-Meyer score (FMA-LE) | Assesses sensory and movement related functions in the lower extremity (0p max impairment summed up to 86p max no detected impairment) | At baseline, weekly during the intervention and after completion of the 4 week intervention to assess change. | |
Secondary | Neuroflexor | Medical technology device. Assesses spasticity by identifying the neural, viscous and elastic components during passive movement using a biomechanical algorithm (presented in Newton) | At baseline, weekly during the intervention, and after completion of the 4 week intervention to assess change. | |
Secondary | Modified Ashworth scale 0-5 | Assesses spasticity on a 6 point scale/muscle (0p no impairment, 5p max impairment/muscle) | At baseline, weekly during the intervention and after completion of the 4 week intervention, to assess change. | |
Secondary | Passive range of motion in the lower extremity | Clinical assessment of range of motion with a goniometer | At baseline, weekly during the intervention and after completion of the 4 week intervention to assess change. | |
Secondary | Medical Research Council scale | Assesses muscle strength on a 6 point scale/muscle (0p max impairment summed up to 5p no impairment/muscle) | At baseline and after completion of the 4 week intervention | |
Secondary | The Balance evaluation systems test (BEST-test) | Assesses postural control, incorporating bio-mechanical systems, limits of stability, anticipatory postural adjustment, automatic postural responses, sensory orientation, stability in gait (0p max impairment summed up to 108p no impairment) | At baseline, weekly during the intervention and after completion of the 4 week intervention to assess change. | |
Secondary | The 10 meter walk test | Assesses gait speed | At baseline, weekly during the intervention and after completion of the 4 week intervention to assess change. | |
Secondary | 6 minutes walk test | Assesses walking endurance in meters walked | At baseline, weekly during the intervention and after the intervention to assess change | |
Secondary | Rated Perceived Exertion (RPE) Scale | Ratings (min 6, max 20) according to the RPE scale are made at the end of the 6 minutes walk test. | At baseline, weekly during the intervention and after the intervention to assess change | |
Secondary | Indirect Calorimetries | To assess energy expenditure based on respiratory gas exchange. Will be performed during the 6 minutes walk test. | At baseline and after the intervention to assess change | |
Secondary | Electromyography (EMG) | EMG is used to measure muscle activation patterns during gait. | At baseline and after completion of the 4 week intervention to assess change. | |
Secondary | Walking impact scale (MSWS-12 S) | Assesses self-perceived limitations in walking (12p no impairments summed up to 60p max impairment) | At baseline and after completion of the 4 week intervention to assess change. | |
Secondary | The Functional Ambulation Categories (FAC) | Assesses independence in walking (0p nonfunctional, 5p independent) Total score 0-5p | At baseline, weekly during the intervention and after completion of the 4 week intervention to assess change. | |
Secondary | Falls Efficacy Scale (FES-S) | Assesses self perceived balance in every day life activities rated on a 11 point scale (0p not safe at all 10p completely safe). Total score: 0- 130 p | At baseline and after completion of the 4 week intervention to assess change. | |
Secondary | Barthel Index | Assesses independence in mobility and personal care (0p dependent 10/15p independent) Total score 0-100p | At baseline, weekly during the intervention and after completion of the 4 week intervention to assess change. | |
Secondary | Eq-5d-5l | Assesses self perceived health related quality of life in five dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) and on a vertical visual analogue scale. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. Responses are coded as single-digit numbers expressing the severity level selected in each dimension (1 = no problem, 5 = extreme problems). The vertical visual analogue scale is graded from 0-100 (0 = the worst health you can imagine 100 = the best health you can imagine). | At baseline and after completion of the 4 week intervention to assess change. | |
Secondary | A study specific questionnaire - a questionnaire for the experimental group | A questionnaire with 11 questions assessing the patients experience of participating in the study and the use of the FES-system. The patient rates on a 10 graded scale (0 = not at all, 10 = very much): the information given about the study, the experience, usability and comfort of using the system, eventual pain, skin problems and technical problems with the system and experience of eventual benefits from having used the system. | After completion of the 4 week intervention | |
Secondary | Distance accomplished during each training session | The FES-system will collect this data to assess training intensity | Daily during the intervention | |
Secondary | Time accomplished during each training session | The FES-system will collect this data to assess training intensity | Daily during the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Recruiting |
NCT03869138 -
Alternative Therapies for Improving Physical Function in Individuals With Stroke
|
N/A | |
Completed |
NCT04101695 -
Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects
|
N/A | |
Completed |
NCT04034069 -
Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Completed |
NCT00391378 -
Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
|
N/A | |
Recruiting |
NCT06204744 -
Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial
|
N/A | |
Active, not recruiting |
NCT06043167 -
Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
|
||
Active, not recruiting |
NCT04535479 -
Dry Needling for Spasticity in Stroke
|
N/A | |
Completed |
NCT03985761 -
Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke
|
N/A | |
Recruiting |
NCT00859885 -
International PFO Consortium
|
N/A | |
Recruiting |
NCT06034119 -
Effects of Voluntary Adjustments During Walking in Participants Post-stroke
|
N/A | |
Completed |
NCT03622411 -
Tablet-based Aphasia Therapy in the Chronic Phase
|
N/A | |
Completed |
NCT01662960 -
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
|
N/A | |
Recruiting |
NCT05854485 -
Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke
|
N/A | |
Active, not recruiting |
NCT05520528 -
Impact of Group Participation on Adults With Aphasia
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Completed |
NCT05805748 -
Serious Game Therapy in Neglect Patients
|
N/A | |
Recruiting |
NCT05993221 -
Deconstructing Post Stroke Hemiparesis
|